Biotech News 20 Mar 2024 New DNA Origami Platform, DoriVac, Opens New Path for Designer Cancer Vaccine Development The central ingredient of therapeutic cancer vaccines is antigens, which are preferentially produced or newly produced (neoantigens) by tumor cells… Pantitra
BioNet News 12 Mar 2024 BioNet Announces New Scientific Advisory Board Member Dr. William Gruber We are pleased to announce the appointment of Dr. William Gruber as our new Scientific Advisory Board Member. Dr William… Supachai
Biotech News 11 Mar 2024 MIT scientists use a new type of nanoparticle to make vaccines more powerful Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at… Pantitra
BioNet News 07 Mar 2024 BioNet presents at the INMIS 2024 in San Jose, Costa Rica BioNet is pleased to announce its participation in the 6th annual International Neonatology and Maternal Immunization Symposium (INMIS 2024), taking… Supachai
BioNet News 07 Mar 2024 BioNet Announces New Scientific Advisory Board Member Prof. Peter Openshaw We are pleased to announce the appointment of Prof. Peter Openshaw as our new Scientific Advisory Board Member. Peter Openshaw… Supachai
BioNet News 06 Mar 2024 BioNet Announces New Scientific Advisory Board Member Dr. Norbert Pardi We are pleased to announce the appointment of Dr. Norbert Pardi as our new Scientific Advisory Board Member. Dr Norbert… Supachai
Biotech News 04 Mar 2024 Innovative New Vaccine Technology Uses DNA Particles That Pretend To Be Viruses Scientists hope the approach could make it easier to create vaccines against trickier viruses like HIV. A new vaccine against… Pantitra
Biotech News 01 Mar 2024 Study reveals promising potential of Hexaplex vaccine in boosting flu protection A recent study led by a research team from the University at Buffalo has introduced a new recombinant flu vaccine,… Pantitra